Komipharm International Co. Ltd Capital Reinvestment Ratio
Komipharm International Co. Ltd capital reinvestment ratio. Komipharm International Co. Ltd (041960) has a Capital Reinvestment Ratio of 1.95x as of December 2025, meaning it reinvests 2% of its operating cash flow (₩946.94 Million) in capital expenditures (₩1.85 Billion). See Komipharm International Co. Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Komipharm International Co. Ltd (2013–2024)
Capital reinvestment ratio of Komipharm International Co. Ltd from 2013 to 2024. This chart tracks Komipharm International Co. Ltd's Capital Reinvestment Ratio across 6 annual periods. See Komipharm International Co. Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Komipharm International Co. Ltd Capital Reinvestment Ratio by Year (2013–2024)
Komipharm International Co. Ltd capital reinvestment ratio by year from 2013 to 2024. For the full cash flow conversion analysis, see 041960 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.45x | ₩8.85 Billion | ₩3.98 Billion | ▼ -99.3% |
| 2020 | 65.70x | ₩25.20 Million | ₩1.66 Billion | ▲ +988.4% |
| 2019 | 6.04x | ₩950.79 Million | ₩5.74 Billion | ▼ -46.9% |
| 2017 | 11.37x | ₩235.64 Million | ₩2.68 Billion | ▲ +12.3% |
| 2016 | 10.13x | ₩1.21 Billion | ₩12.24 Billion | ▲ +59.8% |
| 2013 | 6.34x | ₩3.93 Billion | ₩24.93 Billion | — |